The long-term outcome for 1,245 patients with carcinoma of the prostat
e treated with external beam radiation therapy is presented. The media
n survival for all patients without evidence of distant metastases but
irrespective of T stage of the primary tumor, histopathological grade
or lymph node status was 10 years compared to 15 years for an age-mat
ched cohort of California men. The cause specific survival at 15 years
was 52%. The data base is subdivided into a series of subsets that de
monstrate the impact of T stage, Gleason pattern score and lymph node
involvement on long-term outcome. The best results were shown in stage
s T1 and T2a cases with histopathologically proved negative lymph node
s. Survival at 15 years was 53%, which was essentially identical to th
e 55% survival rate of an age-matched cohort. The actuarial survival a
t 15 years for all stages T1 and T2N0M0 cancer patients was 45% compar
ed to 56% for an age-matched cohort.